nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—Abnormal pigmentation—Epirubicin—uterine cancer	0.0359	0.0359	CcSEcCtD
Propericiazine—Abnormal pigmentation—Doxorubicin—uterine cancer	0.0332	0.0332	CcSEcCtD
Propericiazine—Hyperpyrexia—Medroxyprogesterone Acetate—uterine cancer	0.0287	0.0287	CcSEcCtD
Propericiazine—Parkinsonism—Medroxyprogesterone Acetate—uterine cancer	0.0235	0.0235	CcSEcCtD
Propericiazine—Embolism venous—Progesterone—uterine cancer	0.0234	0.0234	CcSEcCtD
Propericiazine—Menstruation irregular—Progesterone—uterine cancer	0.0213	0.0213	CcSEcCtD
Propericiazine—Embolism venous—Medroxyprogesterone Acetate—uterine cancer	0.0212	0.0212	CcSEcCtD
Propericiazine—Menstruation irregular—Medroxyprogesterone Acetate—uterine cancer	0.0193	0.0193	CcSEcCtD
Propericiazine—Galactorrhoea—Progesterone—uterine cancer	0.0182	0.0182	CcSEcCtD
Propericiazine—Pigmentation disorder—Etoposide—uterine cancer	0.0181	0.0181	CcSEcCtD
Propericiazine—Deep vein thrombosis—Medroxyprogesterone Acetate—uterine cancer	0.0176	0.0176	CcSEcCtD
Propericiazine—Laryngeal oedema—Medroxyprogesterone Acetate—uterine cancer	0.0166	0.0166	CcSEcCtD
Propericiazine—Galactorrhoea—Medroxyprogesterone Acetate—uterine cancer	0.0165	0.0165	CcSEcCtD
Propericiazine—Menorrhagia—Progesterone—uterine cancer	0.0159	0.0159	CcSEcCtD
Propericiazine—Electrocardiogram ST segment depression—Epirubicin—uterine cancer	0.0149	0.0149	CcSEcCtD
Propericiazine—Menorrhagia—Medroxyprogesterone Acetate—uterine cancer	0.0144	0.0144	CcSEcCtD
Propericiazine—Electrocardiogram ST segment depression—Doxorubicin—uterine cancer	0.0138	0.0138	CcSEcCtD
Propericiazine—Amenorrhoea—Progesterone—uterine cancer	0.0134	0.0134	CcSEcCtD
Propericiazine—Aggression—Progesterone—uterine cancer	0.0134	0.0134	CcSEcCtD
Propericiazine—Jaundice cholestatic—Progesterone—uterine cancer	0.0134	0.0134	CcSEcCtD
Propericiazine—Amenorrhoea—Medroxyprogesterone Acetate—uterine cancer	0.0122	0.0122	CcSEcCtD
Propericiazine—Jaundice cholestatic—Medroxyprogesterone Acetate—uterine cancer	0.0122	0.0122	CcSEcCtD
Propericiazine—Pulmonary embolism—Progesterone—uterine cancer	0.0118	0.0118	CcSEcCtD
Propericiazine—Venous thromboembolism—Epirubicin—uterine cancer	0.0115	0.0115	CcSEcCtD
Propericiazine—Pulmonary embolism—Medroxyprogesterone Acetate—uterine cancer	0.0107	0.0107	CcSEcCtD
Propericiazine—Venous thromboembolism—Doxorubicin—uterine cancer	0.0106	0.0106	CcSEcCtD
Propericiazine—Pigmentation disorder—Epirubicin—uterine cancer	0.0101	0.0101	CcSEcCtD
Propericiazine—Nasal congestion—Progesterone—uterine cancer	0.0094	0.0094	CcSEcCtD
Propericiazine—Pigmentation disorder—Doxorubicin—uterine cancer	0.00938	0.00938	CcSEcCtD
Propericiazine—Increased appetite—Progesterone—uterine cancer	0.00911	0.00911	CcSEcCtD
Propericiazine—Increased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00826	0.00826	CcSEcCtD
Propericiazine—Infection—Carboplatin—uterine cancer	0.00796	0.00796	CcSEcCtD
Propericiazine—Asthma—Progesterone—uterine cancer	0.0074	0.0074	CcSEcCtD
Propericiazine—Sweating increased—Progesterone—uterine cancer	0.00721	0.00721	CcSEcCtD
Propericiazine—Hypokalaemia—Medroxyprogesterone Acetate—uterine cancer	0.00706	0.00706	CcSEcCtD
Propericiazine—Weight increased—Progesterone—uterine cancer	0.00673	0.00673	CcSEcCtD
Propericiazine—Asthma—Medroxyprogesterone Acetate—uterine cancer	0.00671	0.00671	CcSEcCtD
Propericiazine—Embolism venous—Epirubicin—uterine cancer	0.0067	0.0067	CcSEcCtD
Propericiazine—Hyperglycaemia—Progesterone—uterine cancer	0.00668	0.00668	CcSEcCtD
Propericiazine—Pneumonia—Progesterone—uterine cancer	0.00664	0.00664	CcSEcCtD
Propericiazine—Drowsiness—Progesterone—uterine cancer	0.0066	0.0066	CcSEcCtD
Propericiazine—Sweating increased—Medroxyprogesterone Acetate—uterine cancer	0.00653	0.00653	CcSEcCtD
Propericiazine—Jaundice—Progesterone—uterine cancer	0.00643	0.00643	CcSEcCtD
Propericiazine—Body temperature increased—Carboplatin—uterine cancer	0.00633	0.00633	CcSEcCtD
Propericiazine—Embolism venous—Doxorubicin—uterine cancer	0.0062	0.0062	CcSEcCtD
Propericiazine—Weight increased—Medroxyprogesterone Acetate—uterine cancer	0.0061	0.0061	CcSEcCtD
Propericiazine—Hyperglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.00605	0.00605	CcSEcCtD
Propericiazine—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00598	0.00598	CcSEcCtD
Propericiazine—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.00583	0.00583	CcSEcCtD
Propericiazine—Cardiac disorder—Progesterone—uterine cancer	0.0055	0.0055	CcSEcCtD
Propericiazine—Cardiac disorder—Medroxyprogesterone Acetate—uterine cancer	0.00498	0.00498	CcSEcCtD
Propericiazine—Vision blurred—Progesterone—uterine cancer	0.00486	0.00486	CcSEcCtD
Propericiazine—Tremor—Progesterone—uterine cancer	0.00483	0.00483	CcSEcCtD
Propericiazine—Angioedema—Progesterone—uterine cancer	0.00471	0.00471	CcSEcCtD
Propericiazine—Pneumonia—Dactinomycin—uterine cancer	0.00469	0.00469	CcSEcCtD
Propericiazine—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00438	0.00438	CcSEcCtD
Propericiazine—Agranulocytosis—Dactinomycin—uterine cancer	0.00435	0.00435	CcSEcCtD
Propericiazine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00429	0.00429	CcSEcCtD
Propericiazine—Dry mouth—Progesterone—uterine cancer	0.00429	0.00429	CcSEcCtD
Propericiazine—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00427	0.00427	CcSEcCtD
Propericiazine—Confusional state—Progesterone—uterine cancer	0.00424	0.00424	CcSEcCtD
Propericiazine—Oedema—Progesterone—uterine cancer	0.00421	0.00421	CcSEcCtD
Propericiazine—Infection—Progesterone—uterine cancer	0.00418	0.00418	CcSEcCtD
Propericiazine—Tachycardia—Progesterone—uterine cancer	0.00411	0.00411	CcSEcCtD
Propericiazine—Hyperhidrosis—Progesterone—uterine cancer	0.00407	0.00407	CcSEcCtD
Propericiazine—Liver injury—Epirubicin—uterine cancer	0.00402	0.00402	CcSEcCtD
Propericiazine—Hypotension—Progesterone—uterine cancer	0.00393	0.00393	CcSEcCtD
Propericiazine—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00389	0.00389	CcSEcCtD
Propericiazine—Jaundice cholestatic—Epirubicin—uterine cancer	0.00385	0.00385	CcSEcCtD
Propericiazine—Amenorrhoea—Epirubicin—uterine cancer	0.00385	0.00385	CcSEcCtD
Propericiazine—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00384	0.00384	CcSEcCtD
Propericiazine—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00381	0.00381	CcSEcCtD
Propericiazine—Insomnia—Progesterone—uterine cancer	0.00381	0.00381	CcSEcCtD
Propericiazine—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00379	0.00379	CcSEcCtD
Propericiazine—Dyspnoea—Progesterone—uterine cancer	0.00375	0.00375	CcSEcCtD
Propericiazine—Somnolence—Progesterone—uterine cancer	0.00374	0.00374	CcSEcCtD
Propericiazine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00372	0.00372	CcSEcCtD
Propericiazine—Liver injury—Doxorubicin—uterine cancer	0.00372	0.00372	CcSEcCtD
Propericiazine—Sweating increased—Etoposide—uterine cancer	0.00369	0.00369	CcSEcCtD
Propericiazine—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00369	0.00369	CcSEcCtD
Propericiazine—Dyskinesia—Epirubicin—uterine cancer	0.0036	0.0036	CcSEcCtD
Propericiazine—Constipation—Progesterone—uterine cancer	0.0036	0.0036	CcSEcCtD
Propericiazine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00356	0.00356	CcSEcCtD
Propericiazine—Jaundice cholestatic—Doxorubicin—uterine cancer	0.00356	0.00356	CcSEcCtD
Propericiazine—Amenorrhoea—Doxorubicin—uterine cancer	0.00356	0.00356	CcSEcCtD
Propericiazine—Atrioventricular block—Epirubicin—uterine cancer	0.00349	0.00349	CcSEcCtD
Propericiazine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00345	0.00345	CcSEcCtD
Propericiazine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.0034	0.0034	CcSEcCtD
Propericiazine—Pneumonia—Etoposide—uterine cancer	0.00339	0.00339	CcSEcCtD
Propericiazine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00339	0.00339	CcSEcCtD
Propericiazine—Ventricular tachycardia—Epirubicin—uterine cancer	0.00338	0.00338	CcSEcCtD
Propericiazine—Pulmonary embolism—Epirubicin—uterine cancer	0.00338	0.00338	CcSEcCtD
Propericiazine—Dyskinesia—Doxorubicin—uterine cancer	0.00333	0.00333	CcSEcCtD
Propericiazine—Body temperature increased—Progesterone—uterine cancer	0.00333	0.00333	CcSEcCtD
Propericiazine—Jaundice—Etoposide—uterine cancer	0.00329	0.00329	CcSEcCtD
Propericiazine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00326	0.00326	CcSEcCtD
Propericiazine—Atrioventricular block—Doxorubicin—uterine cancer	0.00323	0.00323	CcSEcCtD
Propericiazine—Agranulocytosis—Etoposide—uterine cancer	0.00315	0.00315	CcSEcCtD
Propericiazine—Pulmonary embolism—Doxorubicin—uterine cancer	0.00313	0.00313	CcSEcCtD
Propericiazine—Ventricular tachycardia—Doxorubicin—uterine cancer	0.00313	0.00313	CcSEcCtD
Propericiazine—Hypersensitivity—Progesterone—uterine cancer	0.0031	0.0031	CcSEcCtD
Propericiazine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00301	0.00301	CcSEcCtD
Propericiazine—Oedema—Dactinomycin—uterine cancer	0.00297	0.00297	CcSEcCtD
Propericiazine—Infection—Dactinomycin—uterine cancer	0.00295	0.00295	CcSEcCtD
Propericiazine—Diarrhoea—Progesterone—uterine cancer	0.00288	0.00288	CcSEcCtD
Propericiazine—Cardiac disorder—Etoposide—uterine cancer	0.00281	0.00281	CcSEcCtD
Propericiazine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00281	0.00281	CcSEcCtD
Propericiazine—Photosensitivity—Epirubicin—uterine cancer	0.0028	0.0028	CcSEcCtD
Propericiazine—Vomiting—Progesterone—uterine cancer	0.00268	0.00268	CcSEcCtD
Propericiazine—Rash—Progesterone—uterine cancer	0.00265	0.00265	CcSEcCtD
Propericiazine—Dermatitis—Progesterone—uterine cancer	0.00265	0.00265	CcSEcCtD
Propericiazine—Increased appetite—Epirubicin—uterine cancer	0.00261	0.00261	CcSEcCtD
Propericiazine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00261	0.00261	CcSEcCtD
Propericiazine—Photosensitivity—Doxorubicin—uterine cancer	0.00259	0.00259	CcSEcCtD
Propericiazine—Nausea—Progesterone—uterine cancer	0.0025	0.0025	CcSEcCtD
Propericiazine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00242	0.00242	CcSEcCtD
Propericiazine—Increased appetite—Doxorubicin—uterine cancer	0.00242	0.00242	CcSEcCtD
Propericiazine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.0024	0.0024	CcSEcCtD
Propericiazine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.0024	0.0024	CcSEcCtD
Propericiazine—Body temperature increased—Dactinomycin—uterine cancer	0.00235	0.00235	CcSEcCtD
Propericiazine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00226	0.00226	CcSEcCtD
Propericiazine—Hypokalaemia—Epirubicin—uterine cancer	0.00223	0.00223	CcSEcCtD
Propericiazine—Hypersensitivity—Dactinomycin—uterine cancer	0.00219	0.00219	CcSEcCtD
Propericiazine—Confusional state—Etoposide—uterine cancer	0.00217	0.00217	CcSEcCtD
Propericiazine—Infection—Etoposide—uterine cancer	0.00214	0.00214	CcSEcCtD
Propericiazine—Asthma—Epirubicin—uterine cancer	0.00212	0.00212	CcSEcCtD
Propericiazine—Tachycardia—Etoposide—uterine cancer	0.0021	0.0021	CcSEcCtD
Propericiazine—Eosinophilia—Epirubicin—uterine cancer	0.0021	0.0021	CcSEcCtD
Propericiazine—Hyperhidrosis—Etoposide—uterine cancer	0.00208	0.00208	CcSEcCtD
Propericiazine—Hypokalaemia—Doxorubicin—uterine cancer	0.00207	0.00207	CcSEcCtD
Propericiazine—Diarrhoea—Dactinomycin—uterine cancer	0.00204	0.00204	CcSEcCtD
Propericiazine—Hypotension—Etoposide—uterine cancer	0.00201	0.00201	CcSEcCtD
Propericiazine—Asthma—Doxorubicin—uterine cancer	0.00196	0.00196	CcSEcCtD
Propericiazine—Eosinophilia—Doxorubicin—uterine cancer	0.00194	0.00194	CcSEcCtD
Propericiazine—Photosensitivity reaction—Epirubicin—uterine cancer	0.00194	0.00194	CcSEcCtD
Propericiazine—Weight increased—Epirubicin—uterine cancer	0.00193	0.00193	CcSEcCtD
Propericiazine—Dyspnoea—Etoposide—uterine cancer	0.00192	0.00192	CcSEcCtD
Propericiazine—Hyperglycaemia—Epirubicin—uterine cancer	0.00191	0.00191	CcSEcCtD
Propericiazine—Somnolence—Etoposide—uterine cancer	0.00191	0.00191	CcSEcCtD
Propericiazine—Pneumonia—Epirubicin—uterine cancer	0.0019	0.0019	CcSEcCtD
Propericiazine—Drowsiness—Epirubicin—uterine cancer	0.00189	0.00189	CcSEcCtD
Propericiazine—Vomiting—Dactinomycin—uterine cancer	0.00189	0.00189	CcSEcCtD
Propericiazine—Rash—Dactinomycin—uterine cancer	0.00188	0.00188	CcSEcCtD
Propericiazine—Jaundice—Epirubicin—uterine cancer	0.00184	0.00184	CcSEcCtD
Propericiazine—Constipation—Etoposide—uterine cancer	0.00184	0.00184	CcSEcCtD
Propericiazine—Photosensitivity reaction—Doxorubicin—uterine cancer	0.00179	0.00179	CcSEcCtD
Propericiazine—Weight increased—Doxorubicin—uterine cancer	0.00179	0.00179	CcSEcCtD
Propericiazine—Hyperglycaemia—Doxorubicin—uterine cancer	0.00177	0.00177	CcSEcCtD
Propericiazine—Nausea—Dactinomycin—uterine cancer	0.00177	0.00177	CcSEcCtD
Propericiazine—Agranulocytosis—Epirubicin—uterine cancer	0.00177	0.00177	CcSEcCtD
Propericiazine—Pneumonia—Doxorubicin—uterine cancer	0.00176	0.00176	CcSEcCtD
Propericiazine—Drowsiness—Doxorubicin—uterine cancer	0.00175	0.00175	CcSEcCtD
Propericiazine—Jaundice—Doxorubicin—uterine cancer	0.00171	0.00171	CcSEcCtD
Propericiazine—Body temperature increased—Etoposide—uterine cancer	0.0017	0.0017	CcSEcCtD
Propericiazine—Agranulocytosis—Doxorubicin—uterine cancer	0.00163	0.00163	CcSEcCtD
Propericiazine—Hypersensitivity—Etoposide—uterine cancer	0.00159	0.00159	CcSEcCtD
Propericiazine—Cardiac disorder—Epirubicin—uterine cancer	0.00158	0.00158	CcSEcCtD
Propericiazine—Arrhythmia—Epirubicin—uterine cancer	0.00152	0.00152	CcSEcCtD
Propericiazine—Diarrhoea—Etoposide—uterine cancer	0.00147	0.00147	CcSEcCtD
Propericiazine—Cardiac disorder—Doxorubicin—uterine cancer	0.00146	0.00146	CcSEcCtD
Propericiazine—Arrhythmia—Doxorubicin—uterine cancer	0.0014	0.0014	CcSEcCtD
Propericiazine—Vision blurred—Epirubicin—uterine cancer	0.00139	0.00139	CcSEcCtD
Propericiazine—Vomiting—Etoposide—uterine cancer	0.00137	0.00137	CcSEcCtD
Propericiazine—Agitation—Epirubicin—uterine cancer	0.00136	0.00136	CcSEcCtD
Propericiazine—Rash—Etoposide—uterine cancer	0.00136	0.00136	CcSEcCtD
Propericiazine—Dermatitis—Etoposide—uterine cancer	0.00136	0.00136	CcSEcCtD
Propericiazine—Vision blurred—Doxorubicin—uterine cancer	0.00129	0.00129	CcSEcCtD
Propericiazine—Nausea—Etoposide—uterine cancer	0.00128	0.00128	CcSEcCtD
Propericiazine—Agitation—Doxorubicin—uterine cancer	0.00126	0.00126	CcSEcCtD
Propericiazine—Dry mouth—Epirubicin—uterine cancer	0.00123	0.00123	CcSEcCtD
Propericiazine—Confusional state—Epirubicin—uterine cancer	0.00122	0.00122	CcSEcCtD
Propericiazine—Oedema—Epirubicin—uterine cancer	0.00121	0.00121	CcSEcCtD
Propericiazine—Infection—Epirubicin—uterine cancer	0.0012	0.0012	CcSEcCtD
Propericiazine—Tachycardia—Epirubicin—uterine cancer	0.00118	0.00118	CcSEcCtD
Propericiazine—Hyperhidrosis—Epirubicin—uterine cancer	0.00117	0.00117	CcSEcCtD
Propericiazine—Dry mouth—Doxorubicin—uterine cancer	0.00114	0.00114	CcSEcCtD
Propericiazine—Hypotension—Epirubicin—uterine cancer	0.00113	0.00113	CcSEcCtD
Propericiazine—Confusional state—Doxorubicin—uterine cancer	0.00113	0.00113	CcSEcCtD
Propericiazine—Oedema—Doxorubicin—uterine cancer	0.00112	0.00112	CcSEcCtD
Propericiazine—Infection—Doxorubicin—uterine cancer	0.00111	0.00111	CcSEcCtD
Propericiazine—Insomnia—Epirubicin—uterine cancer	0.00109	0.00109	CcSEcCtD
Propericiazine—Tachycardia—Doxorubicin—uterine cancer	0.00109	0.00109	CcSEcCtD
Propericiazine—Hyperhidrosis—Doxorubicin—uterine cancer	0.00108	0.00108	CcSEcCtD
Propericiazine—Dyspnoea—Epirubicin—uterine cancer	0.00108	0.00108	CcSEcCtD
Propericiazine—Somnolence—Epirubicin—uterine cancer	0.00107	0.00107	CcSEcCtD
Propericiazine—Hypotension—Doxorubicin—uterine cancer	0.00104	0.00104	CcSEcCtD
Propericiazine—Constipation—Epirubicin—uterine cancer	0.00103	0.00103	CcSEcCtD
Propericiazine—Insomnia—Doxorubicin—uterine cancer	0.00101	0.00101	CcSEcCtD
Propericiazine—Dyspnoea—Doxorubicin—uterine cancer	0.000995	0.000995	CcSEcCtD
Propericiazine—Somnolence—Doxorubicin—uterine cancer	0.000993	0.000993	CcSEcCtD
Propericiazine—Constipation—Doxorubicin—uterine cancer	0.000955	0.000955	CcSEcCtD
Propericiazine—Body temperature increased—Epirubicin—uterine cancer	0.000954	0.000954	CcSEcCtD
Propericiazine—Hypersensitivity—Epirubicin—uterine cancer	0.000889	0.000889	CcSEcCtD
Propericiazine—Body temperature increased—Doxorubicin—uterine cancer	0.000883	0.000883	CcSEcCtD
Propericiazine—Diarrhoea—Epirubicin—uterine cancer	0.000826	0.000826	CcSEcCtD
Propericiazine—Hypersensitivity—Doxorubicin—uterine cancer	0.000823	0.000823	CcSEcCtD
Propericiazine—Vomiting—Epirubicin—uterine cancer	0.000767	0.000767	CcSEcCtD
Propericiazine—Diarrhoea—Doxorubicin—uterine cancer	0.000764	0.000764	CcSEcCtD
Propericiazine—Rash—Epirubicin—uterine cancer	0.000761	0.000761	CcSEcCtD
Propericiazine—Dermatitis—Epirubicin—uterine cancer	0.00076	0.00076	CcSEcCtD
Propericiazine—Nausea—Epirubicin—uterine cancer	0.000717	0.000717	CcSEcCtD
Propericiazine—Vomiting—Doxorubicin—uterine cancer	0.00071	0.00071	CcSEcCtD
Propericiazine—Rash—Doxorubicin—uterine cancer	0.000704	0.000704	CcSEcCtD
Propericiazine—Dermatitis—Doxorubicin—uterine cancer	0.000703	0.000703	CcSEcCtD
Propericiazine—Nausea—Doxorubicin—uterine cancer	0.000663	0.000663	CcSEcCtD
